Source: Markets Insider

Eli Lilly: Lilly announces new clinical data from Verzenio and oral SERD programs at the American Society of Clinical Oncology annual meeting

New exploratory analysis of a pre-specified subgroup of patients with HR+, HER2- high risk early breast cancer who received neoadjuvant chemothera...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
David A. Ricks's photo - Chairman & CEO of Eli Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating


Read more